Dipyridamole Induced Ischemia and Biomarkers

NCT03688815 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2018-09-28

No results posted yet for this study

Summary

Analysis of certain biomarkers and transient myocardial perfusion deficit revealed by myocardial perfusion scintigraphy.

Conditions

  • Ischemic Heart Disease
  • Ischemic Attack

Interventions

DIAGNOSTIC_TEST

myocardial perfusion scintigraphy

Myocardial perfusion scintigraphy as it is described in the international literature.

Sponsors & Collaborators

  • University of Pecs

    lead OTHER

Principal Investigators

  • Tihamer Molnar, MD · University of Pecs

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-01
Primary Completion
2010-01-01
Completion
2017-01-01

Countries

  • Hungary

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03688815 on ClinicalTrials.gov